z-logo
open-access-imgOpen Access
Reasons why patients fail screening in Indian breast cancer trials
Author(s) -
Pratiksha Mahajan,
Apoorva Kulkarni,
Sriniwas B Narayanswamy,
Jignesh Dalal,
Vipul Halbe,
Shraddha Patkar,
Amit Bhatt
Publication year - 2015
Publication title -
perspectives in clinical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.649
H-Index - 8
eISSN - 2229-5488
pISSN - 2229-3485
DOI - 10.4103/2229-3485.167100
Subject(s) - medicine , clinical trial , informed consent , breast cancer , patient recruitment , protocol (science) , cancer , alternative medicine , pathology
An increased number of screen failure patients in a clinical trial increases time and cost required for the recruitment. Assessment of reasons for screen failure can help reduce screen failure rates and improve recruitment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here